Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial

Authors

Institutions

Publication Details

Journal
The Lancet Oncology
Published
2026-01-07
DOI
https://doi.org/10.1016/s1470-2045(25)00653-9
Citations
2
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
70.83
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial

Nitin Patel, J. San‐Miguel, Phoebe Joy Ho, Surbhi Sidana et al.
2 citations
The Lancet Oncology
Multiple Myeloma Research and Treatments
70.83
article

Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial

Nitin Patel, J. San‐Miguel, Phoebe Joy Ho, Surbhi Sidana, Erika Florendo, Nikoletta K. Lendvai, Vicki Plaks, Mythili Koneru, Martinez-Lopez Joaquin, Arnab Ghosh, Diana Chen, Tzu-min Yeh, Albert Oriol, Xavier P Leleu, Binod Dhakal, Cyrille Touzeau, Carolina Lonardi, Ana Slaughter, Yael Chava Cohen, Rakesh Popat, Jordan Mark Schecter, Martin Vogel, Simon James Harrison, Paolo Corradini, Nina Benachour, María-Victoria Mateos, Lionel Karlin, Niels WCJ van de Donk, Hermann Einsele, Katherine Li, Quanlin Li
article en
2 citations

Abstract

No abstract available for this paper.
The Lancet OncologyVol. 27(2)
Centre National de la Recherche Scientifique (FR), Johnson & Johnson (United States) (US), University College London Hospitals NHS Foundation Trust (GB), Inserm (FR), Universidad de Salamanca (ES), Medical College of Wisconsin (US), Royal Prince Alfred Hospital (AU), Tel Aviv Sourasky Medical Center (IL), Peter MacCallum Cancer Centre (AU), Université de Poitiers (FR), Johnson & Johnson (Switzerland) (CH), 490 BioTech (United States) (US), Universitäts-Kinderklinik Würzburg (DE), Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (FR), Centre Hospitalier Universitaire de Poitiers (FR), Hôpital Lyon Sud (FR), Johnson & Johnson (Germany) (DE), Johnson Electric (China) (CN), Instituto de Investigación Biomédica de Salamanca (ES), Clinica Universidad de Navarra (ES), Johnson & Johnson (Israel) (IL), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES), Centro de Investigación del Cáncer (ES), Amsterdam University Medical Centers (NL), Hospital Universitari Germans Trias i Pujol (ES), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), University College London (GB), Vrije Universiteit Amsterdam (NL), Stanford University (US), Nantes Université (FR)
Openalex Percentile: Top 0%
Multiple Myeloma Research and Treatments
70.83
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.